These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 2554908)
1. Differential susceptibility to biological detergents of the particulate cGMP-stimulated phosphodiesterase from rat heart: preservation of the allosteric properties of the solubilized enzyme. Timouyasse L; Prigent AF; Némoz G; Lagarde M; Pachéco H Biochem Int; 1989 Aug; 19(2):287-99. PubMed ID: 2554908 [TBL] [Abstract][Full Text] [Related]
2. Dissimilar cyclic nucleotide phosphodiesterase activities in subcellular fractions from normal and SV40-transformed WI-38 fibroblasts. Nemecek GM; Butcher RW J Cyclic Nucleotide Res; 1979 Dec; 5(6):449-61. PubMed ID: 94064 [TBL] [Abstract][Full Text] [Related]
3. [Kinetic properties and regulation of cyclic nucleotide phosphodiesterases in lymphoid cells]. Azhaeva EV; Severin ES Bioorg Khim; 1987 Sep; 13(9):1157-63. PubMed ID: 2827690 [TBL] [Abstract][Full Text] [Related]
4. Alterations in cyclic AMP phosphodiesterase activities during differentiation of 3T3-L1 cells. Manganiello VC; Reed BC; Lieberman FS; Moss J; Lane MD; Vaughan M J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(2):143-54. PubMed ID: 6196386 [TBL] [Abstract][Full Text] [Related]
5. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents. Marcoz P; Prigent AF; Lagarde M; Nemoz G Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905 [TBL] [Abstract][Full Text] [Related]
6. Specific effects of n-3 fatty acids and 8-bromo-cGMP on the cyclic nucleotide phosphodiesterase activity in neonatal rat cardiac myocytes. Picq M; Dubois M; Grynberg A; Lagarde M; Prigent AF J Mol Cell Cardiol; 1996 Oct; 28(10):2151-61. PubMed ID: 8930810 [TBL] [Abstract][Full Text] [Related]
7. Cyclic nucleotide derivatives as probes of phosphodiesterase catalytic and regulatory sites. Erneux C; Couchie D; Dumont JE; Jastorff B Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():107-18. PubMed ID: 6326517 [TBL] [Abstract][Full Text] [Related]
8. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord. de Vente J; Markerink-van Ittersum M; Vles JS J Chem Neuroanat; 2006 Jun; 31(4):275-303. PubMed ID: 16621445 [TBL] [Abstract][Full Text] [Related]
10. A comparative kinetic study of bovine calmodulin-dependent cyclic nucleotide phosphodiesterase isozymes utilizing cAMP, cGMP and their 2'-O-anthraniloyl-,2'-O-(N-methylanthraniloyl)-derivatives as substrates. Grewal J; Karuppiah N; Mutus B Biochem Int; 1989 Dec; 19(6):1287-95. PubMed ID: 2561449 [TBL] [Abstract][Full Text] [Related]
11. Characterization of a liver low Michaelis-Menten constant 3',5'-cyclic adenosine monophosphate phosphodiesterase activity sensitive to thyroid status. Benelli C; Geoffroy V; Fouque F; Lopez S; Desbuquois B Endocrinology; 1991 May; 128(5):2376-86. PubMed ID: 1850351 [TBL] [Abstract][Full Text] [Related]
12. Aggregation states of cyclic nucleotide phosphodiesterase of murine thymocytes. Sobolev AS; Rybalkin SD Cell Biochem Funct; 1986 Jul; 4(3):205-11. PubMed ID: 3015450 [TBL] [Abstract][Full Text] [Related]
13. Cyclic nucleotide phosphodiesterase-mediated integration of cGMP and cAMP signaling in cells of the cardiovascular system. Maurice DH Front Biosci; 2005 May; 10():1221-8. PubMed ID: 15769620 [TBL] [Abstract][Full Text] [Related]
14. Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors. Rutten K; Prickaerts J; Hendrix M; van der Staay FJ; Sik A; Blokland A Eur J Pharmacol; 2007 Mar; 558(1-3):107-12. PubMed ID: 17207788 [TBL] [Abstract][Full Text] [Related]
15. Relationship between inhibition of cardiac muscle phosphodiesterases, changes in cyclic nucleotide levels, and contractile response for CI-914 and other novel cardiotonics. Weishaar RE; Quade MM; Schenden JA; Evans DB J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(6):551-64. PubMed ID: 3003170 [TBL] [Abstract][Full Text] [Related]
16. Distribution and regulation of the phosphodiesterases of muscle tissues. Gain KR; Appleman MM Adv Cyclic Nucleotide Res; 1978; 9():221-31. PubMed ID: 208376 [No Abstract] [Full Text] [Related]
17. [Phosphodiesterase characteristics of the fat cells in spontaneous hypertension in rats]. Reznikova MB; Postnov IuV Kardiologiia; 1980 Sep; 20(9):72-6. PubMed ID: 6252365 [TBL] [Abstract][Full Text] [Related]
18. [Ca2+-calmodulin-activated cyclic nucleotide phosphodiesterase from the soluble fraction of the human brain: Kinetic properties and the effect of the antidepressant pyrazidol and its nitro analog on the enzyme]. Medvedeva MV; Belov AA; Kireeva NN; Bobruskin ID Biokhimiia; 1993 May; 58(5):798-808. PubMed ID: 8393348 [TBL] [Abstract][Full Text] [Related]
19. Activation of cyclic AMP phosphodiesterase by a new vitamin E derivative. Sakai T; Okano T; Makino H; Tsudzuki T J Cyclic Nucleotide Res; 1976; 2(3):163-70. PubMed ID: 180065 [TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships. Ko WC; Shih CM; Lai YH; Chen JH; Huang HL Biochem Pharmacol; 2004 Nov; 68(10):2087-94. PubMed ID: 15476679 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]